Psoriasis Risk Higher for Patients With Eczema Treated With Dupilumab

Three-year cumulative psoriasis incidence higher for those receiving dupilumab versus other systemic agents
sensitive skin rash
Adobe Stock
Medically Reviewed By:
Meeta Shah, M.D.
Published on: 
Updated on: 
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com